KEC International Ltd.

Similar documents
Piramal Enterprises Ltd.

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

Independent Equity Research. Investment Summary

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

KNR Constructions Robust Performance on Execution Ramp-up

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

Force Motors Limited

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

KPR Mills Ltd 1QFY18 Result Update Target: Rs 944. Textile revenue impacted by slowdown due to GST, recovery from 2QFY18 onwards

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

INDEX. Aequitas Investment

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Stock Data Sector Gems. Stock Performance (%) Shareholding Pattern (%) Sensex and stock movement. Company Update Gems India Research

SKS Textiles Limited (NSE SME)

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

All these indications point to a bright and an exciting future for Lypsa

Manappuram Finance (MGFL IN) Growth picks up in gold loan; Microfinance drive profitability

CMP: Stock Data Sector. Stock Performance (%) Shareholding Pattern (%) Sensex and stock movement. 6 th March, 2017

PGCIL Order Inflow Analysis

Institutional Equities

Robust results, TLT margins improved profitability.

Colgate-Palmolive (India)

Century Plyboards (India)

Tata Elxsi Ltd. CMP: Rs. 1,192 Future Stallion.. BUY. Stock Data. Stock Performance (%) Company Update IT Software India Research

Manappuram Finance (MGFL IN) Healthy operating performance

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Initiating Coverage. Uflex Ltd.

HCL Technologies. Rating: Target price: EPS: Target CMP. Rating. Rs. 826 REDUCE. Rs.760

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

KWG. Seeking balance between scale and profitability. March 27, 2018 Equity Research. Stock code: 1813.HK Rating: HOLD Price target (HK$) 12.

Balkrishna Industries

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

Ambuja Cements. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.225. Rs. 195

Century Plyboards (India)

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Gillette India. Institutional Equities. 1QFY18 Result Update

MARKET RECAP. Instrument Close

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

BHEL (BHEL IN) Weak execution and margins lead to the miss in earnings

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

Adani Ports & SEZ Rating: Target price: EPS:

Reliance Capital Builder Fund II Series C (A Close Ended Equity Oriented Scheme)

KDDL (KDDL IN) In expansion mode

Havells India. Q3FY17 Result Update Positive surprise; Maintain Buy. Sector: Consumer Durable CMP: ` 376. Recommendation: BUY.

Bajaj Auto Ltd. CMP: Rs.1426 Recommendation: Buy Target Price: Rs March. 1 P age. 21 st July Key Data Financial Year End

Wipro. 4QFY18 Result Update. Still not of the woods, maintain Hold. Sector: Technology CMP: ` 287. Recommendation: Hold

Havells India. Q4FY16 Result Update In-line result; Consistent improvement in performance. Sector: Consumer Durable CMP: ` 342. Recommendation: BUY

CR Lands. Winner of next 5 years, BUY. March 21, 2018 Equity Research. Stock code: 1109.HK Rating: BUY Price target (HK$) 34.74

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

General Insurance Corporation of India Ltd.

Fineotex Chemical Ltd

MCX Ltd. Rating: Target price: EPS: Is commodity option a game changer for MCX? - Unlikely. Target. Rating CMP. Rs. 1,080 SELL. Rs.

Key estimate revision. Financial summary. Year FY15 121, % 16, % FY16E 137, % 20,

TTK Prestige. Channel-check takeaways Growth recovery pace sees moderation, competitive headwinds continue to prevail. Target CMP. Rating Rs.

Visaka Industries Ltd

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Source: Company Data; PL Research

Mandhana Industries Ltd.

NIIT Technologies. 3QFY19 Result Update. Robust revenue visibility, Outlook robust

EBITDA 5,076 3, , EBITDA

Equitas Holdings. Rating: Target price: ABV: Target CMP. Rating. Rs Rs. 226 BUY

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

RPP Infra Projects Limited (BOM ) (NSE RPPINFRA)

Transcription:

Investment Summary KEC International Ltd. Independent Equity Research March - 2016 Equentis Wealth Advisory Services (P) Ltd Registered Office: 712, Raheja Chambers, Nariman Point, Mumbai 400021 India Tel: +91 22 61013800 Email: info@researchandranking.com

Quantitative Factors - Checklist KEC INTERNATIONAL LIMITED Sr. No. Aspect Required Criteria for Equentis 5x5 strategy F10-15 Actual Value (Historical) Condition Met? (/N) F16-21E Future Value (Forecasted) Condition Met? (/N) 1 Top-line 20-30% over 5yr period 17% N 17% N 2 EBITDA 25-35% over 5yr period 6% N 21% N 3 PAT 30-40% over 5yr period (3)% N 32% 4 ROCE 5 D/E Ratio At least 15% with increasing bias Around 1-1.5xs with declining bias Avg - 19%. Avg -1.3x Avg - 21%.Steady rise from 14.6% in F15 to 24% in F21E Avg 1.1x Steady drop from 1.5x in F15 to 1.0x in F21E 6 Working Capital Intensity Less than 25-30% of net sales Avg 16.3% Avg 16.7% 7 Dividend Payout 15-20% Avg - 20% Avg - 20% Note: - On revenue and operating profit growth front KEC does not meet Equentis criteria for company selection, however it qualifies on the basis of expected growth in net profits. Further return ratios and capital structure of the company is expected to improve significantly going forward, following the expected rise in profitability and capital efficiency. We believe that it is the growth in net profits and improvement in return parameters that will determine the company s valuation trajectory going forward, hence KEC qualifies to be the part of Equentis s 5x5 universe. 2

Qualitative Factors - Checklist Sr.No. Aspect Comment Required Criteria for Equentis 5x5 strategy- Met? Part of the RPG Group, one of India s leading business houses 1 Management pedigree, track record and integrity Successfully grown business through a balanced diversification strategy Established a large global enterprise through acquisitions and partnerships Maintains regular interactions within external stake holders ensuring consistent information flow with adequate disclosures Promoters have consistently increased their stake in the company to over 50%. 2 Ownership Profile None of promoter holding is pledged Institutional holding high at 30%+ - some prominent investors include names like UTI, LIC of India and Fidelity Growth Partners, a PE fund with USD 300 bn assets under management. Strong capability in executing EPC projects with over 7 decades of track record KEC is the largest power T&D EPC player in India having ~25-30% market share in PGCIL orders 3 Business USP & Market Leadership A prominent player in the international markets as well, where it enjoys strong local presence in some of the key growth regions such as Americas and Africa. Flexible business model backed by balanced revenue flows from international and domestic operations New levers for growth in place with entry in other infra EPC space including railways and water treatment. 4 Past strategies towards acquisitions, capital allocation, fiscal prudence, capital spends, cash flow mgmt, dividend payouts, bonus, concern for minority s/hs 5 Succession Planning Strong management focus on capital efficiency improvement- consistently stayed ahead of peers in working capital management and thereby earning high return ratios Average capex has been maintained below 3.3% of sales during past 5 years, which includes its overseas acquisition of USD 95 mn in F11 Company has handsomely rewarded investors with average dividend payouts of ~20% since F09. KEC is part of a large group with 3 rd generation involved in operations of the Group s other ventures A professionally managed company with Mr. Vimal Kejriwal, a veteran in the industry having over 3 decades of experience, at the helm of operations. 3

Highlights 1. We are positive on the growth prospects of KEC in the coming years. Our outlook on the company finds strength from its leadership position in the power T&D segment in India coupled with its strong presence in the international geographies. We believe that the company is best placed in the sector to benefit from the expected growth in order flows. 2. T&D Order inflow gaining traction There is relatively high visibility on domestic ordering activity, whereas trajectory for international orders is difficult to predict at this point in time. Even if we assume international order flows to slow down over the next 1-2 years (even though management interactions indicate no cause of worry), we believe that the growth in domestic ordering will keep KEC on track to achieve the estimated 17-18% growth in topline over F16-21 ( Rs 200 bn in F21 against Rs 90 bn in F16). Here we would like to point out that in our projections we have not assumed a significant rise in contribution from the company s non-t&d EPC segments, such as railways, cables, Water treatment and Solar, which together constitute ~15% of the order book. We are very optimistic about the growth prospects of all the non-t&d segments as well but await higher traction in order flows to take a decisive view on the growth trajectory that these segments may chart out going forward. We believe that the non-t&d segments can provide a huge upside trigger going forward and thereby boost order book growth even further. 3. Margin expansion underway - Margins which were under pressure since F12 due to increase in competitive intensity in the domestic market, reduced profitability in SAE operations and entry into new business verticals, are set to improve as the company completes all the legacy orders by the end of F16 and as SAE operations as well as new business verticals turnaround. Going forward we expect the operating margins to improve by almost 200 bps to reach 8.8% by F21. 4. Improving capital structure supported by higher capital efficiency In view of no large capex plan and the proposed savings in working capital, we believe that KEC can support 20-25% growth (absolute basis) in revenue for the next 2-3 years through internal accruals itself. In the latest interaction also, management has reiterated its target for working capital reduction and has expressed its confidence in improving leverage by maintaining debt at current levels (Rs 20-21 billion) to support future sales growth. We therefore anticipate interest cost as a percentage to sales to come down as well as capital structure to improve substantially with D:E reaching ~1.0x level by F21 as compared to 1.54x reported in F15. 5. Strong growth in net profits- Healthy growth in sales, improvement in profitability, low depreciation and interest costs as a proportion to sales should translate in the PAT margins to go up grow from 1.9% in F15 to 3.8% by F21. Resultantly, we expect 4.0x growth in PAT i.e. of 32.3% over F16-21 to Rs 7.4 billion. EPS of Rs 6.3 in F15 is projects to increase to Rs 28.7 by F21. 6. A notable global player in the T&D EPC space- KEC is the largest T&D EPC player in India with nearly double the size of operations as compared to its nearest competitor in the space. Domestically the company has maintained its lead in PGCIL orders and currently holds close to 25-30% market share. Further RPG Group s vision of setting up a truly global enterprise has enabled KEC to emerge as a strong contender in the global power T&D arena, wherein it is ranked no.1 in South & North America and in Africa, while enjoying a prominent position in the Middle Eastern markets. Further due to geographically diversified revenue mix and efficient capital management, KEC has stayed ahead of its peers in terms of sales growth and return parameters as well. 4

Valuations & Recommendation Increase in cash flows from operations, limited capex and rationalization of capital structure should translate in 4.0x growth in net profit of the company. Overall we project EPS of the Company to increase from Rs 6.3 per share in F15, to Rs 7.1 in F16 (o growth 13%) and further to Rs 28.7 by F21, implying an EPS of 32.3% over F16-21. KEC currently trades at a PE of 16x on the consolidated TTM EPS of Rs 6.8. Over the next 4-5 years we expect the stock price to grow by 4.5-5.0x, this is arrived at by valuing the F21 EPS of Rs 28.7 at 18-20x PE. Valuation reflects our confidence in the management capability in capturing high growth opportunities both in India and in the overseas market. Our outlook also finds strength from its leadership position in the power T&D segment and its superiority in managing working capital requirement as compared to its peers. We therefore believe that KEC is best placed in the sector to benefit from the expected growth in order flows. The table below details the sensitivity of F21 target price to different levels of EPS estimates and PE multiples. F-21 EPS sensitivity -15% -10% -5% 0% 5% 10% 15% F-21 EPS est. (Rs./-) 24.4 25.8 27.2 28.7 30.1 31.5 33.0 PE 14xs 341.0 361.0 381.1 401.1 421.2 441.3 461.3 PE 16xs 389.7 412.6 435.5 458.4 481.4 504.3 527.2 PE 18xs 438.4 464.2 490.0 515.8 541.5 567.3 593.1 PE 20xs 487.1 515.8 544.4 573.1 601.7 630.4 659.0 PE 22xs 535.8 567.3 598.8 630.4 661.9 693.4 724.9 PE 24xs 584.5 618.9 653.3 687.7 722.1 756.4 790.8 PE 26xs 633.2 670.5 707.7 745.0 782.2 819.5 856.7 Note shaded cells indicate fair value of equity range Recommendation- We are very positive on the overall growth story that is unfolding for KEC and therefore strongly recommend buying into the stock for the long term investors, having 4-5 years investment horizon. At the current market price of Rs 110-115, KEC can be a strong value creator, with over 4.5-5.0x return potential over the next five year period. Risks to the recommendation Slowdown in order flows Entire growth in revenue hinges upon the expectation of order pick up in the domestic markets in the immediate term and sustained strength in the international markets. In case there are delays in domestic tendering process or international markets continue to languish beyond estimated time period, then our projections would face the risk of downward revision. Subsidiary and new vertical turn around- Our assumption on margin expansion assumes turnaround in SAE operations and improvement in the performance of new verticals from F16 onward and would need to be monitored closely for any deviations. Capital efficiency improvement Interest outgo will increase for the company if it is unable to improve working capital efficiency as targeted or undertakes higher than Rs 1,000 million p.a. capex over the next 2-3 years impacting the growth in PAT during the projection period Input cost fluctuation- KEC derives sizable revenue from international operations (~53% of revenue in F15), which are fixed price in nature and therefore are vulnerable to adverse input cost movements. The company tries to mitigate this risk by hedging the exposure to the extent possible but there are always some uncovered positions in its order book. 5

Consolidated Financial Summary Consolidated (INR mn) F11 F12 F13 F14 F15 F16E F17E F18E F19E F20E F21E 3yr (F12-15) 5yr (F10-15) 3yr (F16-19E) Gross Revenues 45,712 59,177 71,187 80,927 86,573 89,988 98,596 113,033 134,473 162,808 199,773 13.5% 17.0% 14.3% 17.3% o 15.7% 29.5% 20.3% 13.7% 7.0% 3.9% 9.6% 14.6% 19.0% 21.1% 22.7% Net Revenues 44,765 58,147 69,795 79,018 84,678 88,060 96,484 110,612 131,592 159,320 195,494 13.3% 16.7% 14.3% 17.3% o 14.6% 29.9% 20.0% 13.2% 7.2% 4.0% 9.6% 14.6% 19.0% 21.1% 22.7% EBITDA 5,200 5,059 4,307 5,566 5,779 6,759 7,757 9,225 10,975 13,765 17,282 4.5% 5.6% 17.5% 20.7% o 18.3% -2.7% -14.9% 29.2% 3.8% 16.9% 14.8% 18.9% 19.0% 25.4% 25.5% EBITDA margins 11.6% 8.7% 6.2% 7.0% 6.8% 7.7% 8.0% 8.3% 8.3% 8.6% 8.8% Reported PAT 2,056 2,093 650 668 1,610 1,816 2,597 3,525 4,386 5,688 7,366-8.4% -3.2% 34.2% 32.3% o 8.4% 1.8% -68.9% 2.6% 141.2% 12.8% 43.0% 35.7% 24.4% 29.7% 29.5% PAT margins 4.6% 3.6% 0.9% 0.8% 1.9% 2.1% 2.7% 3.2% 3.3% 3.6% 3.8% FCFF -2,171 4,485-2,188-925 2,134 2,777 3,035 3,634 2,159 1,135 1,739 Debt:Equity 1.43 1.01 1.27 1.52 1.54 1.36 1.22 1.07 1.02 1.03 1.02 Asset turns 1.93 2.57 2.65 2.63 2.51 2.54 2.61 2.77 2.88 2.92 2.99 Net working capital/gross sales 20.4% 11.2% 13.3% 15.2% 16.9% 16.8% 16.8% 16.3% 16.3% 16.8% 16.8% Capex/Gross sales 10.4% 3.1% 2.4% 1.2% -0.6% 1.1% 1.0% 0.9% 1.5% 1.8% 2.0% ROCE 20.6% 21.1% 15.1% 16.5% 14.6% 16.9% 18.7% 20.9% 21.9% 23.2% 24.4% RoE 21.7% 18.9% 5.7% 5.6% 12.1% 12.4% 15.6% 18.2% 19.3% 21.0% 22.5% EBIT/Gross Interest Expense 3.0 2.3 1.6 1.5 1.3 2.1 2.3 2.7 2.9 3.1 3.3 Shares o/s (mn) 257.1 257.1 257.1 257.1 257.1 257.1 257.1 257.1 257.1 257.1 257.1 EPS 8.0 8.1 2.5 2.6 6.3 7.1 10.1 13.7 17.1 22.1 28.7 P/E 16.8 14.9 10.4 7.7 6.2 4.7 3.7 EV: 45,382 44,830 44,888 44,946 47,335 51,917 57,332 - M. cap 26,994 26,994 26,994 26,994 26,994 26,994 26,994 - Add: debt 20,451 20,037 20,306 20,717 23,236 27,950 33,466 - Less: cash & cash equivalents (2,063) (2,202) (2,412) (2,765) (2,895) (3,027) (3,128) EV/EBITDA 7.9 6.6 5.8 4.9 4.3 3.8 3.3 BVPS 36.8 43.1 44.6 46.3 51.7 57.1 64.9 75.3 88.4 105.3 127.2 P/BV 2.0 1.8 1.6 1.4 1.2 1.0 0.8 Dividend payout - as % of PAT 17.4% 17.1% 23.4% 27.0% 16.9% 20.0% 20.0% 20.0% 20.0% 20.0% 20.0% 5yr (F16-21E) 6

DISCLAIMER Equentis Wealth Advisory Services Private Limited (EWASPL) is registered under the SEBI (Investment Advisers) Regulations, 2013. Research & Ranking is the brand under which the Research Division of EWASPL render s its Research Services. General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by EWASPL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through EWASPL nor any solicitation or offering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by EWASPL to be reliable. EWASPL or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, affiliates or representatives of EWASPL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely affected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces affecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be affected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may affect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by EWASPL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. EWASPL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to EWASPL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in Mumbai (India). Disclosure of Interest: The Research Analyst(s) who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of EWASPL, Research Analyst(s), or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. EWASPL, the Research Analyst(s), or their relativesdo not have financial interest in the issuer company(ies) of the said securities nor have ownership of 1% or more individually or jointly till the date of this Report. EWASPL, the Research Analyst(s), or their relatives have not received any compensation or other benefits from the said issuer company(ies) in last 12 months in any respect whatsoever. Copyright: The copyright in this Report belongs exclusively to EWASPL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of EWASPL. EWASPL s activities were never suspended by SEBI or any other authority. Further, there does not exist any material adverse order/judgments/strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against EWASPL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. CIN: U74999MH2015PTC262812; SEBI Registration No.:INA000003874 7